Current issues in the pathology of ovarian cancer.
The majority of primary ovarian tumors are histologically classified as surface epithelial-stromal neoplasms. The malignant potential of such neoplasms may be categorized, on the basis of the extent of epithelial proliferation and stromal invasion, as benign, borderline or malignant. Recent efforts to further classify the malignant potential of such neoplasms have produced a new system for the histologic grading of ovarian carcinoma as well as new potential histologic predictors of behavior, including micropapillary morphology and stromal microinvasion in serous tumors. Among mucinous ovarian neoplasms, new criteria have been proposed to distinguish primary ovarian from metastatic carcinomas; the distinction may be difficult but has great clinical significance. The origin of ovarian mucinous tumors associated with pseudomyxoma peritonei has been reassessed. Finally, recent pathologic findings from prophylactic salpingo-oophorectomy specimens in patients with hereditary risks for ovarian carcinoma have highlighted the additional risk for fallopian tube carcinoma and primary peritoneal carcinoma. Special processing of the pathologic specimens is required to detect early and minimal neoplasia in this setting. These current issues in the pathology of ovarian carcinoma and their clinical significance form the basis of this review.
Rabban
Joseph T
JT
Gillette Center in Women's Cancer Pathology and Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Bell
Debra A
DA
D003536:Cystadenocarcinoma / Q000145:classification / Q000473:pathology*; D018282:Cystadenocarcinoma, Mucinous / Q000145:classification / Q000473:pathology; D018284:Cystadenocarcinoma, Serous / Q000145:classification / Q000473:pathology; D005260:Female; D006801:Humans; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000145:classification / Q000473:pathology*; D016019:Survival Analysis; D016896:Treatment Outcome